CDKN2B-AS1 and nasopharyngeal carcinoma: Consistent with this, lncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes cancer progression via reprogramming cell glucose metabolism and inducing side-population stem-like cancer cells [47].